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1380Objective: The recent advent of robotically assisted surgery has enabled totally endoscopic repair of atrial septal
defects and patent foramen ovale. This study investigates the feasibility and safety of totally endoscopic repair of
an atrial septal defect through small incisions on the chest without robotic assistance.
Methods: Forty patients (23 female patients; average age, 15.4  8.7 years; age range, 6–47 years) with
secundum-type ASDs were selected for this study. Cardiopulmonary bypass was achieved peripherally. Through
3-port incisions in the right chest, pericardiotomy, bicaval occlusion, atriotomy, and ASD repair were performed
by a surgeon through a thoracoscopy.
Results: The cardiopulmonary bypass and aortic crossclamp times were 56.2  21.1 and 38.3  8.6 minutes,
respectively. The length of stay in the intensive care unit was 23.0 4.1 hours. There were no mortalities and no
major complications in this cohort. Patients were discharged from the hospital 4 to 6 days after the operation.
Transesophageal echocardiographic analysis immediately after the operation and at 30 days showed complete
closure of the defect without residual shunt.
Conclusions: Totally endoscopic atrial septal defect repair can be achieved without a robotically assisted sur-
gical system. This technique is safe and effective and can be used as a therapeutic option for ASD. (J Thorac
Cardiovasc Surg 2011;141:1380-3)Atrial septal defect (ASD) is one of the most common con-
genital cardiac defects. Many ASDs can now be closed with
septal occluder devices through cardiac catheterization.1
However, the need for subsequent surgical rescue after
catheter-based ASD repair was more common than reoper-
ation in patients undergoing surgical closure.1 In addition,
large ASDs might not be suitable for transcatheter closure
and require primary surgical repair.2 Minimally invasive
surgical approaches have been applied to repair ASDs to
minimize surgical trauma and improve cosmetic results.3-6
In recent years, totally endoscopic techniques have also
been developed for ASD closure.6-10 Totally endoscopic
procedures require the aid of computer and robotic
technologies and are associated with excellent success
rates in ASD closure and low complication rates.4-8
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The Journal of Thoracic and Cardiovascular Surwithout a robotically assisted surgical system has not
been previously investigated. In this study we report our
single-center experience with totally endoscopic repair of
ASDs through 3 small incisions in the right chest.
MATERIALS AND METHODS
Patient Selection
This study was approved by the Institutional Review Board of Liao-
cheng People’s Hospital. Written informed consent was obtained from
all participants before the study. Between June 2009 and April 2010, pa-
tients with ASDs were selected from the Department of Cardiac Surgery
for this study. The selection criteria were as follows: (1) 5 years of age
or older with a body weight of 20 kg or more; (2) pulmonary arterial sys-
tolic pressure measured by means of echocardiographic analysis of 60 mm
Hg or less; (3) no previous history of lung disease or operations on the right
chest; and (4) no other cardiovascular diseases or chronic illnesses. Patients
who were unable to meet all of the above selection criteria or unable to
provide informed consent were excluded from this study.
Anesthesia
After induction of general anesthesia, a left-sided double-lumen
endotracheal tube (for patients with body weight 50 kg) or single-
lumen endotracheal tube (body weight<50 kg) was placed to allow for
single-lung ventilation. The respiration rate was set between 18 and 30
breaths/min, and the arterial oxygen saturation rate was maintained at
greater than 97%.
Surgical Techniques
The patient was positioned in the supine position with the right side of
the body elevated to 15 to 20. After systemic heparinization, the right
femoral artery and vein were accessed through an oblique incision along
the inguinal crease, as previously reported by Bonaros and colleagues.10
A 24F/29F Carpentier double-lumen catheter (Medtronic, Inc, Minneapo-
lis, Minn) was inserted through the right femoral vein into the inferior andgery c June 2011
FIGURE 1. Location of the 3 ports on the right chest wall.
Abbreviations and Acronyms
ASD ¼ atrial septal defect
CPB ¼ cardiopulmonary bypass
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or 21F catheter (Medtronic, Inc) in the abdominal aorta through the right
femoral artery.
Three small incisions (ports) were made on the right side of the chest
(Figure 1). Port 1 (1–1.5 cm) was located in the fourth intercostal space
on the right side of the sternum (Figure 1). This port was for the insertion
of surgical instruments, such as tissue forceps or suture needles, using the
left hand (for a right-handed operator). Port 2 (1–1.5 cm) was for the entry
of instruments, such as scissors, handled by the right hand of the operator
and is located in the sixth intercostal space on a midclavicular line
(Figure 1). Port 3 (1.5–2.0 cm) was located in the fifth intercostal space
on the right midaxillary line (Figure 1). This port was for the placement
of an endoscopic camera or thoracoscopy (Figure 2). A self-made plastic
retractor was inserted into each of the 3 ports to keep them open and to
facilitate the insertion or withdrawal of the instruments or thoracoscopy
(Figure 2).
Once the 3 ports were secured, a pericardiotomy was performed, and 3
to 4 sutures were placed to suspend the pericardium. Caval snares were
placed in the superior and inferior vena cavae to install total cardiopulmo-
nary bypass (CPB). After CPB initiation and cooling to 32C, the thoraco-
scopy was placed through port 2 to visualize the root of the aorta. An aortic
crossclamp was positioned on the ascending aorta (Figure 3). A needle was
inserted through port 3 to the aortic root for the delivery of cold cardiople-
gic solution to achieve cardiac arrest (Figure 3). The thoracoscopy was re-
positioned through port 3 to visualize the right atrium. A tissue forceps and
a scissors were entered through ports 1 and 2, respectively. After snaring of
the superior and inferior vena cavae, the right atriumwas opened from a site
parallel to the atrioventricular annulus, and 4 stay sutures were placed on
the incision to expose the intra-atrial structure. The ASD was closed
with direct 4–0 Prolene sutures (Ethicon, Inc, Somerville, NJ; Figure 4).
A bovine patch (BairenMed Pharma Co, Beijing, China) was used to repair
larger ASDS with running Prolene sutures.
After ASD closure, the aortic crossclamp was released. The patient was
rewarmed and weaned from CPB. The integrity of the ASD closure was
confirmed by means of transesophageal echocardiographic analysis. Prot-
amine sulfate (1:1) was administered to counteract the actions of heparin.
After adequate hemostasis was achieved, all instruments were removed
from the chest, and a 24F chest tube was inserted in the right pleural space
through port 2 for drainage after removal of the cannulas and reconstruction
of the right femoral artery and femoral vein.
Perioperative Management
Before surgical intervention, education and counseling were provided to
all participants on surgical techniques, possible clinical outcomes, poten-
tial complications, and postoperative self-care measures. Lung function
tests were routinely performed on all patients before the operation. The
lungs were inflated every 20 minutes during the operation. After the oper-
ation, patients were monitored in the intensive care unit overnight and
received low-frequency, high-volume mechanical ventilation with a peak
end-expiratory pressure of 3 to 5 cmH2O. Bedside chest radiographic anal-
ysis was routinely performed in the intensive care unit to exclude compli-
cations in the lungs. Furosemide (1 mg/kg administered intravenously once
daily) and methylprednisolone (0.5 mg $ k1 $ d1 administered intrave-
nously once daily) were used in all patients to prevent pulmonary edema.
Mechanical ventilation was ceased once the patient’s hemodynamics and
spontaneous respiration stabilized.The Journal of Thoracic and CarStatistical Analysis
SPSS version 13.0 software (SPSS, Inc, Chicago, Ill) was used for sta-
tistical analysis. Quantitative variables are expressed as means  standard
deviations. Differences between multiple groups were compared by means
of 1-way analysis of variance.RESULTS
Fifty-eight patients with ASDs were initially screened,
and 40 with secundum-type ASDs were finally enrolled in
this study. The main reason for exclusion of patients was
that they either had patent foramen ovale or small
secundum-type ASDs, which were treated with percutane-
ous transcatheter closure by the cardiologists in our hospi-
tal. Five patients with large secundum-type ASDs were
also excluded from this study because of high pulmonary
arterial pressure (>60 mm Hg). The general characteristics
of the 40 selected patients are shown in Table 1.
Totally thoracoscopic ASD repair was successfully per-
formed in all patients, 33 with primary sutures and 7 with
a bovine patch. Patients were subsequently discharged
from the hospital 4 to 6 days after the operation. No patient
underwent reoperation for bleeding. The mean CPB and
aortic crossclamp times were 56.2  21.1 minutes (range,
48–100 minutes) and 38.3  8.6 minutes (range, 25–57
minutes), respectively. Once the aortic clamp was removed,
heart beat resumed spontaneously in 35 patients. In 5 pa-
tients a 50-WDC shock through the chest wall was required
to reboot the heart beat. The mean mechanical ventilation
time was 3.2  1.2 hours (range, 2–19 hours), and the
mean duration of intensive care unit stay was 23.0  4.1
hours (range, 14–28 hours).
The total operative time, CPB time, aortic crossclamp
time, mechanical ventilation time, and duration of intensive
care unit stay of the first and second 10 patients and of the
last 20 patients are listed in Table 2. There is a significantdiovascular Surgery c Volume 141, Number 6 1381
FIGURE 2. Function of each of the 3 ports.
FIGURE 4. Repair of atrial septal defect (ASD).
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crossclamp time in the last 20 patients (P<.01).
Valvuloplasty with the De Vega techniquewas performed
in 3 of the 5 patients immediately after ASD repair in the
same procedure. Follow-up echocardiographic studies
showed no tricuspid regurgitation in the 3 patients.
Eight (20%) patients required intravenous fentanyl
(5–10 mg $ kg1 $ h1) for 1 to 2 days after the operation
for pain relief. The remainder were treated with simple
analgesics, mostly paracetamol. In all patients transesopha-
geal echocardiographic analysis immediately after ASD
repair showed complete closure with no residual shunt.
One (2.5%) patient experienced atrial fibrillation that spon-
taneously returned to sinus rhythm 4 hours after the opera-
tion. Three (7.5%) patients required blood transfusion of
400 mL during the operation. Two (5.0%) patients had right
pulmonary atelectasis, which recovered within 24 hoursFIGURE 3. Ascending aortic crossclamp.
1382 The Journal of Thoracic and Cardiovascular Surafter physiologic therapy on the chest. One (2.5%) patient
had right lung infection, which was successfully treated
with antibiotics. The mean volume of the chest drain was
60  29 mL (range, 30–450 mL). Patients have been fol-
lowed up for 2 to 9 months, with no signs of residual shunt
on transthoracic echocardiographic analysis. There were no
complications from the cannulation sites in the femoral vein
or artery.DISCUSSION
Since the introduction of robotically assisted cardiac
surgery in 1997,11,12 there have been several studies on
endoscopic repair of congenital cardiac defects, such as
ASDs. Initially, this robotically assisted endoscopic
technology was used to maximize visualization of
intracardiac structures by providing enhanced endoscopic
camera control and to facilitate the manipulation of
surgical instruments through limited thoracic incisions.
Later, several authors reported ASD repair entirely through
thoracoscopic port incisions, with a high success rate and
very few complications and with no need for conversion to
full sternotomy or minithoracotomy.6-10 Totally endoscopic
ASD repair minimized the degree of invasiveness,
hastened postoperative recovery, and improved quality of
life, although length of hospital stay was unchanged.9TABLE 1. Baseline characteristic of the 40 selected patients
Indices Values
Age (y) 15.4  8.7 (6–47)
Male sex 17 (42.5%)
Body weight (kg) 36.6  14.6 (20–90)
Diameter of ASD (mm) 26  5 (18–36)
Mild pulmonary hypertension (30–40 mm Hg) 16 (40%)
Moderate pulmonary hypertension (41–60 mm Hg) 3 (7.5%)
Tricuspid regurgitation 5 (12.5%)
Values in parentheses are ranges, where shown. ASD, Atrial septal defect.
gery c June 2011
TABLE 2. Comparison of operational data among three groups of
patients
Patients
1–10
Patients
11–20
Patients
21–40
P
value
Total operative time (min) 142  14 116  9 108  7 .015
CPB time (min) 70  8 54  5 50  4 .007
Aortic crossclamp time (min) 62  4 51  4 31  5 .019
Mechanical ventilation
time (h)
4.1  0.7 3.5  5.3 3.0  6.5 .0001
Intensive care unit stay (h) 26.1  5.2 24.2  8.0 18.1  4.3 .001
Patients 21–40 included the 3 patients who received valvuloplasty in the same
procedure. CPB, Cardiopulmonary bypass.
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a robotic surgical system, which might be a potential issue
for some developing countries in which the high costs of
these computerized systems could be ultimately passed on
to patients. In this study, based on the previously reported en-
doscopic techniques,3-12 we derived a totally thoracoscopic
approach for ASD repair without the aid of a robotically
assisted surgical system. Successful repair of ASDs was
achieved in all patients. The average CPB and aortic
crossclamp times were 56 and 38 minutes, respectively.
There were no major complications and no need for
converting to full sternotomy or minithoracotomy. These
data suggest that totally thoracoscopic repair of an ASD
without robotic assistance is feasible and safe.
Similar to robotically assisted endoscopic techniques,
our approach also faced learning curve issues, with longer
CPB (70 minutes) and aortic crossclamp (62 minutes) times
observed in the first 10 patients. Several investigators
reported intraoperative data from robotically assisted
ASD repair in a smaller number of patients, ranging from
10 to 17.7,8,10 The mean CPB times in these reports varied
from 122 to 161 minutes, and aortic crossclamp times
ranged from 32 to 69 minutes. The mean CPB and aortic
crossclamp times in our first 20 patients were comparable
with those reported by the other investigators,5,7,8,10
except Argenziano and associates,8 who showed an aorticThe Journal of Thoracic and Carcrossclamp time of 32 minutes. In our last 20 patients the
CPB and aortic crossclamp times were reduced to 50 and
31 minutes, respectively. These data suggest that after the
first 20 patients, an operator can achieve totally thoraco-
scopic ASD repair with relatively short CPB and aortic
crossclamp times.
In conclusion, in patients with ASDs, totally thoraco-
scopic repair without robotic assistance is feasible. This
technique is effective and safe and can be used as a therapeu-
tic option for ASD.
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